New York Attorney General Letitia James’ office issued an alert Tuesday asking consumers to report any potential price gouging of at-home testing kits after the office received some reports of testing kits being sold for double or triple their retail price.
The office said it has received reports of BinaxNOW brand tests being “unlawfully” sold for between $40 to $70 per package, when the tests typically cost between $14 to $24 at stores such as Walgreens.
“As New York sees an exponential rise in COVID-19 cases, more and more New Yorkers are looking for at-home tests and other tools in the fight against the coronavirus,” James said in a statement. “If New Yorkers see exorbitant price increases on testing kits or other goods vital and necessary for health, safety and welfare, they are encouraged to report it [to] my office immediately. And fraudsters are on notice that if they attempt to price gouge during this new surge, we will not hesitate to take action.”
New York law prohibits merchants from taking unfair advantage of consumers by selling products “vital to their health, safety or welfare for an ‘unconscionably excessive’ price,” according to James’ office.
The attorney general also announced Tuesday it issued a warning to Brooklyn-based LabQ Diagnostics for allegedly misrepresenting its COVID-19 test turnaround time.
In a letter to the lab, which has mobile locations throughout New York City, the attorney general said some consumers have reportedly been waiting over 96 hours for COVID-19 test results to come back, even though the lab advertised that results would come back within 48 hours.
The letter, dated Monday, instructed the lab to update its website and signage at its test sites “immediately” to reflect how long people can expect to wait before they receive their test results.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI